This year's prestigious award in medical science has been awarded for transformative discoveries that illuminate how the body's defense network attacks harmful infections while sparing the body's own cells.
Three renowned scientists—from Japan Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this honor.
Their research identified unique "sentinels" within the immune system that eliminate malfunctioning defense cells that could harming the body.
The findings are now enabling new treatments for autoimmune diseases and cancer.
These laureates will share a prize fund valued at 11 million SEK.
"Their work has been decisive for comprehending how the immune system functions and the reason we do not all develop severe self-attack conditions," stated the chair of the award panel.
This team's research explain a core mystery: How does the defense system defend us from numerous invaders while leaving our healthy cells intact?
The body's protection system employs immune cells that search for signs of infection, even viruses and germs it has not met before.
These defenders employ detectors—called recognition units—that are produced by chance in a vast number of variations.
That provides the defense network the ability to combat a wide array of threats, but the randomness of the mechanism unavoidably creates immune cells that can attack the body.
Scientists earlier understood that a portion of these problematic white blood cells were destroyed in the immune organ—where white blood cells mature.
This year's Nobel Prize honors the identification of T-reg cells—known as the body's "peacekeepers"—which travel through the body to neutralize other defenders that assault the healthy cells.
It is known that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.
A prize committee stated, "The discoveries have laid the foundation for a new field of research and spurred the creation of new treatments, for example for tumors and autoimmune diseases."
Regarding cancer, regulatory T-cells prevent the system from fighting the tumor, so studies are focused on reducing their numbers.
In autoimmune diseases, trials are testing boosting regulatory T-cells so the organism is no longer being harmed. A comparable approach could also be effective in reducing the chances of organ transplant failure.
Professor Sakaguchi, of Osaka University, performed experiments on rodents that had their immune gland extracted, leading to self-attack conditions.
He demonstrated that injecting immune cells from healthy mice could prevent the disease—implying there was a system for preventing immune cells from attacking the body.
Dr. Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic autoimmune disease in rodents and humans that led to the identification of a gene critical for the way regulatory T-cells operate.
"Their pioneering work has uncovered how the body's defenses is controlled by T-reg cells, preventing it from accidentally attacking the healthy cells," said a leading biological science expert.
"The research is a striking example of how fundamental physiological research can have broad consequences for public health."
A seasoned casino enthusiast and gaming analyst with over a decade of experience in slot machine mechanics and strategies.
